Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

Bibliographic Details
Main Authors: Mohammad Munshi, MD, Alexandra Junge, Karolina Gadaldi, MD, Nikhil Yawalkar, MD, Kristine Heidemeyer, MD
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:JAAD Case Reports
Subjects:
acute generalized exanthematous pustulosis
hydroxychloroquine
ixekizumab
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512620303660

Internet

http://www.sciencedirect.com/science/article/pii/S2352512620303660

Similar Items